Scopus
YÖKSİS DOI Eşleşti
SJR Q3
Various Carbonic Anhydrases in Physiopathological Events, Carbonic Anhydrase Inhibitors, and Hybrid Compounds
Letters in Drug Design and Discovery · Ocak 2023
Özet
Enzymes are highly specific catalysts that accelerate reactions in biological systems. Carbonic anhydrase (CA) is an enzyme found in plants, microorganisms, and vertebrates. CA catalyses CO2 hydra-tion/dehydration. There are different families and isoenzymes of CAs. Fifteen α-CA isoenzymes have been reported in humans. The status of CO2 hydration and dehydration is important for a variety of biological processes. CAs play an important role in many physiological and pathological events in several tissue types. Their levels are increased in some diseases; therefore, CA inhibition has been applied as a therapeutic option. However, the high diversity of these isoenzymes is an important consideration. Isoen-zyme-specific CA inhibitors can reduce the side effects of treatment. Some agents containing additional sulfonamides approved for other therapeutic applications, such as topiramate, celecoxib/valdecoxib, sul-piride, and famotidine, have inhibitory effects on CA isoenzymes. These bind to the zinc ion in the CA active site. Recently, research has been conducted on the use of a hybrid form of active ingredient and a CA inhibitor. CA inhibitor-NSAID hybrid compounds demonstrated more efficacy than NSAIDs in ar-thritis, which has attracted further attention of researchers in conducting research on CA-hybrid drugs.
YÖKSİS Kayıtları
Various Carbonic Anhydrases in Physiopathological Events, Carbonic Anhydrase Inhibitors, and Hybrid Compounds
Letters in Drug Design & Discovery · 2023 SCI-Expanded
Prof. Dr. AYŞE ER →
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 8 kaydı bulundu.
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 8 kaydı bulundu.
Cytotoxicity of Hydrazones of Morpholine Bearing Mannich Bases towards Huh7 and T47D Cell lines and Their Effects on Mitochondrial Respiration
2016 ISSN: 15701808 SCI-Expanded
Prof. Dr. KAAN KÜÇÜKOĞLU →
Inhibition of DNA Topoisomerases by a Series of Benzoxazoles and their Possible Metabolites
2018 ISSN: 15701808 SCI-Expanded
Dr. Öğr. Üyesi FATMA ZİLİFDAR FOTO →
Analytical Procedures for Secondary Metabolites Determination: Recent Trends and Future Perspectives
2018 ISSN: 1570-1808 SCI-Expanded
Prof. Dr. GÖKHAN ZENGİN →
Various Carbonic Anhydrases in Physiopathological Events, Carbonic Anhydrase Inhibitors, and Hybrid Compounds
2023 ISSN: 1570-1808 SCI-Expanded Q4
Prof. Dr. AYŞE ER →
Design, Synthesis, and Biological Evaluation of Some Novel Retinoid Derivatives
2024 ISSN: 1570-1808 SCI-Expanded Q4
Dr. Öğr. Üyesi FATMA ZİLİFDAR FOTO →
Computational Bioactivity Analysis and Bioisosteric Investigation of the Approved Breast Cancer Drugs Proposed New Design Drug Compounds: Increased Bioactivity Coming with Silicon and Boron
2021 ISSN: 1570-1808 SCI Q4
Doç. Dr. ESMA ERYILMAZ DOĞAN →
Short-term Administration of Naringin Improves Renal Function in Renal Ischemia-reperfusion by Increasing Aquaporin-1 and Aquaporin-2 Levels
2024 ISSN: 1570-1808 SCI-Expanded
Prof. Dr. RASİM MOĞULKOÇ →
Short-term Administration of Naringin Improves Renal Function in Renal Ischemia-reperfusion by Increasing Aquaporin-1 and Aquaporin-2 Levels
2024 ISSN: 1570-1808 SCI-Expanded Q4
Prof. Dr. ABDULKERİM KASIM BALTACI →
Makale Bilgileri
Toplam Atıf
5 atıf
· Scopus
ISSN15701808
Yayın TarihiOcak 2023
Cilt / Sayfa20 · 1427-1436
Scopus ID2-s2.0-85161640284
Kurumlar
Selçuk Üniversitesi
Selçuklu Turkey
Havuzumuzdaki Atıflar 0
Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 5.
Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi (ISSN Eşleşmesi)
Letters in Drug Design and Discovery
Q3
SJR Skoru0,301
H-Index41
YayıncıKeAi Communications Co.
ÜlkeChina
Drug Discovery (Q3)
Pharmaceutical Science (Q3)
Molecular Medicine (Q4)
Metrikler
5
Atıf